Drug recall · August 28, 2013
IRINOTECAN HYDROCHLORIDE INJECTION recall
Why: Crystallization: Active pharmaceutical ingredient is precipitating in product solution.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
IRINOTECAN HYDROCHLORIDE INJECTION, 40 mg/2 mL (20 mg/mL), 2 mL Single Dose Vial, Rx only, Manufactured for: APP Pharmaceuticals, LLC, Schaumburg, IL 60173, NDC 63323-193-02, UPC 3 63323 19302 7.
- Lots / codes
Lot #: 872CZ00101, Exp 12/13
- Quantity
- 23,672 vials
- Company
- Fresenius Kabi USA LLC (FK USA), Schaumburg, IL
- Distribution
- Nationwide
- Initiated
- January 22, 2013 · Voluntary: Firm initiated
- Classified
- August 21, 2013
- Reported
- August 28, 2013
- Ended
- May 12, 2015
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Irinotecan
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.